After engraftment of the tumor cells for 3 days, the mice were treated either with a single dose of PBS, 3 × 106 control T cells or 3 × 106 anti-CD30 CAR T-cells (CD30-28BBz). The gene discussed is TNFRSF8; the disease is neoplasm.